These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16198451)

  • 1. Pneumococcal vaccine efficacy for mucosal pneumococcal infections depends on Fcgamma receptor IIa polymorphism.
    Wiertsema SP; Veenhoven RH; Walraven V; Uiterwaal CS; Schilder AG; Rijkers GT; Sanders EA
    Vaccine; 2006 Feb; 24(6):792-7. PubMed ID: 16198451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumococcal conjugate vaccination does not induce a persisting mucosal IgA response in children with recurrent acute otitis media.
    Bogaert D; Veenhoven RH; Ramdin R; Luijendijk IH; Rijkers GT; Sanders EA; de Groot R; Hermans PW
    Vaccine; 2005 Apr; 23(20):2607-13. PubMed ID: 15780443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fcgamma receptor IIA H/R131 polymorphism in patients with antiphospholipid antibodies.
    Atsumi T; Caliz R; Amengual O; Khamashta MA; Hughes GR
    Thromb Haemost; 1998 May; 79(5):924-7. PubMed ID: 9609222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of pneumococcal vaccination on quality of life in children with recurrent acute otitis media: a randomized, controlled trial.
    Brouwer CN; Maillé AR; Rovers MM; Veenhoven RH; Grobbee DE; Sanders EA; Schilder AG
    Pediatrics; 2005 Feb; 115(2):273-9. PubMed ID: 15687432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of combined pneumococcal conjugate and polysaccharide vaccination on recurrent otitis media with effusion.
    van Heerbeek N; Straetemans M; Wiertsema SP; Ingels KJ; Rijkers GT; Schilder AG; Sanders EA; Zielhuis GA
    Pediatrics; 2006 Mar; 117(3):603-8. PubMed ID: 16510637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia.
    Yee AM; Phan HM; Zuniga R; Salmon JE; Musher DM
    Clin Infect Dis; 2000 Jan; 30(1):25-8. PubMed ID: 10619728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.
    Ekström N; Väkeväinen M; Verho J; Kilpi T; Käyhty H
    Infect Immun; 2007 Apr; 75(4):1794-800. PubMed ID: 17261612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fcgamma receptor polymorphisms determine the magnitude of in vitro phagocytosis of Streptococcus pneumoniae mediated by pneumococcal conjugate sera.
    Jansen WT; Breukels MA; Snippe H; Sanders LA; Verheul AF; Rijkers GT
    J Infect Dis; 1999 Sep; 180(3):888-91. PubMed ID: 10438387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
    Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
    Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of IgG subclasses and C-reactive protein in lupus nephritis: the relationship between the composition of immune deposits and FCgamma receptor type IIA alleles.
    Zuniga R; Markowitz GS; Arkachaisri T; Imperatore EA; D'Agati VD; Salmon JE
    Arthritis Rheum; 2003 Feb; 48(2):460-70. PubMed ID: 12571856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients.
    Bazilio AP; Viana VS; Toledo R; Woronik V; Bonfá E; Monteiro RC
    Nephrol Dial Transplant; 2004 Jun; 19(6):1427-31. PubMed ID: 15004265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric determination of FcgammaRIIa (CD32) polymorphism.
    van Royen-Kerkhof A; Sanders EA; Wijngaarden S; van Roon JA; Voorhorst-Ogink M; Walraven V; Gerritsen A; van Dijk MA; Kuis W; Rijkers GT; Keler T; Leusen JH; van de Winkel JG
    J Immunol Methods; 2004 Nov; 294(1-2):135-44. PubMed ID: 15604023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing vaccine efficacy for the prevention of acute otitis media by pneumococcal vaccination in children: a methodological overview of statistical practice in randomized controlled clinical trials.
    Jahn-Eimermacher A; du Prel JB; Schmitt HJ
    Vaccine; 2007 Aug; 25(33):6237-44. PubMed ID: 17629378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of pneumococcal vaccination in children younger than 24 months: a meta-analysis.
    Pavia M; Bianco A; Nobile CG; Marinelli P; Angelillo IF
    Pediatrics; 2009 Jun; 123(6):e1103-10. PubMed ID: 19482744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media.
    Emonts M; Veenhoven RH; Wiertsema SP; Houwing-Duistermaat JJ; Walraven V; de Groot R; Hermans PW; Sanders EA
    Pediatrics; 2007 Oct; 120(4):814-23. PubMed ID: 17908769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of carriage of hemoglobin AS and the Fc gamma receptor IIa-R131 allele on levels of immunoglobulin G2 antibodies to Plasmodium falciparum merozoite antigens in Gabonese children.
    Ntoumi F; Flori L; Mayengue PI; Matondo Maya DW; Issifou S; Deloron P; Lell B; Kremsner PG; Rihet P
    J Infect Dis; 2005 Dec; 192(11):1975-80. PubMed ID: 16267770
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total and serotype-specific pneumococcal antibody titres in children with normal and abnormal humoral immunity.
    Uddin S; Borrow R; Haeney MR; Moran A; Warrington R; Balmer P; Arkwright PD
    Vaccine; 2006 Jul; 24(27-28):5637-44. PubMed ID: 16730399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The FcgammaRIIa polymorphism influences production of interleukin-1 by mononuclear cells.
    Yamamoto K; Kobayashi T; Sugita N; Tai H; Yoshie H
    Int J Immunogenet; 2007 Oct; 34(5):369-72. PubMed ID: 17845308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies.
    Siber GR; Chang I; Baker S; Fernsten P; O'Brien KL; Santosham M; Klugman KP; Madhi SA; Paradiso P; Kohberger R
    Vaccine; 2007 May; 25(19):3816-26. PubMed ID: 17368878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New vaccines against otitis media: projected benefits and cost-effectiveness.
    O'Brien MA; Prosser LA; Paradise JL; Ray GT; Kulldorff M; Kurs-Lasky M; Hinrichsen VL; Mehta J; Colborn DK; Lieu TA
    Pediatrics; 2009 Jun; 123(6):1452-63. PubMed ID: 19482754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.